JCR Pharmaceuticals CoJCRRF 65 Median PS Value is $12.20 as of Jun. 30, 2026, which is 1120% above its 10-year median of 1.00. GuruFocus rates JCRRF with a GF Score™ of 65/100 and a GF Value™ of $5.21 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 544 Drug Manufacturers companies, JCR Pharmaceuticals Co ranks better than 93.93% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for JCR Pharmaceuticals Co's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of JCR Pharmaceuticals Co was 2.88. The lowest was 0.33. And the median was 1.00.
JCRRF's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.84 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
JCR Pharmaceuticals Co (OTCPK:JCRRF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
JCR Pharmaceuticals Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3.145
/
12.20
=
0.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co Median PS Value Related Terms
JCR Pharmaceuticals Co Median PS Value Historical Data
* Premium members only.
The historical data trend for JCR Pharmaceuticals Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCRRF vs LLY, JNJ, ABBV: Median PS Value Comparison
For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JCR Pharmaceuticals Co Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where JCR Pharmaceuticals Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.6377.
JCR Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.164.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co (JCRRF) has a Median PS Value of $12.20 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on JCR Pharmaceuticals Co and its competitors. This is 1120% above median its historical median of 1.00. Over the past decade, JCR Pharmaceuticals Co's Median PS Value has ranged from 0.33 to 2.88. According to the industry distribution chart, JCR Pharmaceuticals Co ranks #33 out of 544 companies in the Drug Manufacturers industry, placing it in the top 6.1%.
Is JCR Pharmaceuticals Co's Median PS Value too high?
JCR Pharmaceuticals Co's current Median PS Value of $12.20 is 1120% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 2.88. The Drug Manufacturers industry median Median PS Value is 0.84. JCR Pharmaceuticals Co's value of $12.20 is 1352.4% above this industry median. Based on the distribution chart, JCR Pharmaceuticals Co ranks #33 out of 544 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, JCR Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Median PS Value compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, JCR Pharmaceuticals Co ranks #33 out of 544 companies for Median PS Value. This places JCR Pharmaceuticals Co in the top 6% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.84. JCR Pharmaceuticals Co's value of $12.20 is 1352.4% above this benchmark. Historically, JCR Pharmaceuticals Co's own Median PS Value has ranged from 0.33 to 2.88 over the past decade. While the company's 10-year median is 1.00 vs. the industry median of 0.84, JCR Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JCR Pharmaceuticals Co's current Median PS Value of $12.20 is 1352.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on JCR Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JCR Pharmaceuticals Co's current Median PS Value is $12.20, which is 1120% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.21, compared to a current price of $3.15 — trading 39.6% below its estimated fair value. The current Median PS Value is $12.20, which is 1120% above median its 10-year median of 1.00 and 1352.4% above the Drug Manufacturers industry median of 0.84. JCR Pharmaceuticals Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Median PS Value is $12.20 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued.
The current stock price of $3.15 is trading 39.6% below its estimated GF Value™ of $5.21.
GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for JCRRF:
Median PS Value: $12.20 (1120% above median its 10-year median of 1.00)
GF Value™: $5.21 vs. price of $3.15 (39.6% below fair value)
Industry Position: 1352.4% above the Drug Manufacturers median (#33 of 544)
No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
65GF Score
Get the complete analysis for JCRRF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JCRRF has been successfully added to your 
